Valneva is a specialty vaccine company focused on prevention against diseases with major unmet needs. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.

Valneva at a glance

Commercial vaccines for travelers

€m

Product sales revenues in 2019

Unique vaccine development programs

Specialized

Travel vaccines

Vector-transmitted diseases

Focused

On prevention against diseases with major medical needs

> 500

employees in six countries